1 Min Read
(Fixes typo in headline)
July 10 (Reuters) - July 10 (Reuters) - Cangene Corp : * Cancels IGIV development program * Says has cancelled its product development program for immune globulin intravenous
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.